IE
LABU icon

Israel Englander’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Israel Englander’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
+1,000
New +$191K ﹤0.01% 5126
2022
Q3 		– Sell
-5,784
Closed -$780K – 7303
2022
Q2 		$780K Buy
+5,784
New +$985K ﹤0.01% 4600
2020
Q4 		– Sell
-228
Closed -$245 – 5410
2020
Q3 		$245 Buy
+228
New +$261K ﹤0.01% 3969

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Israel Englander's LABU Position: Q2 2026 in Review

Israel Englander opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 1,000 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #5126 among its holdings. This is a return to the name: Israel Englander previously reported a position in LABU as recently as Q2 2022.

Israel Englander first reported a position in LABU in Q3 2020 and has held it in 3 quarters since. The position peaked at $780K in Q2 2022. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Israel Englander held 1,000 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $292K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Israel Englander position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5126 holding.
  • Israel Englander first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2020 and has held it in 3 quarters since.
  • Israel Englander's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $780K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.